Dr. Jennifer Grossman, business development manager of the Pilot Bioproduction Facility at the Walter Reed Army Institute of Research, presented on the capabilities of the PBF at the annual World Vaccine Congress conference held in Washington D.C., April 2025.
The PBF is a cGMP-compliant facility that specializes in the production of early-stage clinical trial material, particularly vaccines and biologics. It plays a key role in supporting U.S. military and public health medical countermeasure efforts.
Dr. Grossman and other team members from WRAIR’s PBF joined more than 1,000 researchers and stakeholders at WVC 2025, one of the largest international events focused on vaccine development and manufacturing. The conference attracts top scientists, companies, and government officials from around the world. Attendees from WRAIR participated in workshops, panels, and poster sessions covering topics ranging from innovations in vaccine technology to the manufacturing of mRNA vaccines, monoclonal antibodies, and other biologics.
Read more on DVIDS
here.